Literature DB >> 31358656

ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1.

Justin P Ingram1, Roshan J Thapa1, Amanda Fisher2, Bart Tummers3, Ting Zhang1, Chaoran Yin1, Diego A Rodriguez3, Hongyan Guo2, Rebecca Lane2, Riley Williams1, Michael J Slifker1, Suresh H Basagoudanavar1, Glenn F Rall1, Christopher P Dillon3, Douglas R Green3, William J Kaiser4, Siddharth Balachandran5.   

Abstract

Receptor-interacting protein kinase 1 (RIPK1) regulates cell fate and proinflammatory signaling downstream of multiple innate immune pathways, including those initiated by TNF-α, TLR ligands, and IFNs. Genetic ablation of Ripk1 results in perinatal lethality arising from both RIPK3-mediated necroptosis and FADD/caspase-8-driven apoptosis. IFNs are thought to contribute to the lethality of Ripk1-deficient mice by activating inopportune cell death during parturition, but how IFNs activate cell death in the absence of RIPK1 is not understood. In this study, we show that Z-form nucleic acid binding protein 1 (ZBP1; also known as DAI) drives IFN-stimulated cell death in settings of RIPK1 deficiency. IFN-activated Jak/STAT signaling induces robust expression of ZBP1, which complexes with RIPK3 in the absence of RIPK1 to trigger RIPK3-driven pathways of caspase-8-mediated apoptosis and MLKL-driven necroptosis. In vivo, deletion of either Zbp1 or core IFN signaling components prolong viability of Ripk1-/- mice for up to 3 mo beyond parturition. Together, these studies implicate ZBP1 as the dominant activator of IFN-driven RIPK3 activation and perinatal lethality in the absence of RIPK1.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Year:  2019        PMID: 31358656      PMCID: PMC6702065          DOI: 10.4049/jimmunol.1900216

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses.

Authors:  Suresh H Basagoudanavar; Roshan J Thapa; Shoko Nogusa; Junmei Wang; Amer A Beg; Siddharth Balachandran
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

2.  DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2012-03-15       Impact factor: 21.023

3.  RIP3, a novel apoptosis-inducing kinase.

Authors:  X Sun; J Lee; T Navas; D T Baldwin; T A Stewart; V M Dixit
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway.

Authors:  Sudan He; Yuqiong Liang; Feng Shao; Xiaodong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  The specific and essential role of MAVS in antiviral innate immune responses.

Authors:  Qinmiao Sun; Lijun Sun; Hong-Hsing Liu; Xiang Chen; Rashu B Seth; James Forman; Zhijian J Chen
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

6.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.

Authors:  Hiroki Ishikawa; Zhe Ma; Glen N Barber
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

7.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity.

Authors:  Leonardo Salmena; Benedicte Lemmers; Anne Hakem; Elzbieta Matysiak-Zablocki; Kiichi Murakami; P Y Billie Au; Donna M Berry; Laura Tamblyn; Amro Shehabeldin; Eva Migon; Andrew Wakeham; Denis Bouchard; Wen Chen Yeh; Jane C McGlade; Pamela S Ohashi; Razqallah Hakem
Journal:  Genes Dev       Date:  2003-03-21       Impact factor: 11.361

9.  TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.

Authors:  Ken J Ishii; Tatsukata Kawagoe; Shohei Koyama; Kosuke Matsui; Himanshu Kumar; Taro Kawai; Satoshi Uematsu; Osamu Takeuchi; Fumihiko Takeshita; Cevayir Coban; Shizuo Akira
Journal:  Nature       Date:  2008-02-07       Impact factor: 49.962

10.  Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene.

Authors:  Katrin Ramsauer; Matthias Farlik; Gordin Zupkovitz; Christian Seiser; Andrea Kröger; Hansjörg Hauser; Thomas Decker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

View more
  26 in total

Review 1.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

Review 2.  Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss.

Authors:  Francesca Maremonti; Claudia Meyer; Andreas Linkermann
Journal:  J Am Soc Nephrol       Date:  2022-01-12       Impact factor: 10.121

3.  ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.

Authors:  Richard de Reuver; Simon Verdonck; Evelien Dierick; Josephine Nemegeer; Eline Hessmann; Sadeem Ahmad; Maude Jans; Gillian Blancke; Filip Van Nieuwerburgh; Alexander Botzki; Lars Vereecke; Geert van Loo; Wim Declercq; Sun Hur; Peter Vandenabeele; Jonathan Maelfait
Journal:  Nature       Date:  2022-07-20       Impact factor: 69.504

4.  Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis.

Authors:  Diego A Rodriguez; Giovanni Quarato; Swantje Liedmann; Bart Tummers; Ting Zhang; Cliff Guy; Jeremy Chase Crawford; Gustavo Palacios; Stephane Pelletier; Halime Kalkavan; Jeremy J P Shaw; Patrick Fitzgerald; Mark J Chen; Siddharth Balachandran; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

Review 5.  RIPK3 signaling and its role in the pathogenesis of cancers.

Authors:  Shanhui Liu; Kanak Joshi; Mitchell F Denning; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2021-10-15       Impact factor: 9.207

Review 6.  The clearance of dead cells by efferocytosis.

Authors:  Emilio Boada-Romero; Jennifer Martinez; Bradlee L Heckmann; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2020-04-06       Impact factor: 94.444

Review 7.  Inflammatory microenvironment remodelling by tumour cells after radiotherapy.

Authors:  Martin McLaughlin; Emmanuel C Patin; Malin Pedersen; Anna Wilkins; Magnus T Dillon; Alan A Melcher; Kevin J Harrington
Journal:  Nat Rev Cancer       Date:  2020-03-11       Impact factor: 60.716

8.  ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer.

Authors:  Jin Young Baik; Zhaoshan Liu; Delong Jiao; Hyung-Joon Kwon; Jiong Yan; Chamila Kadigamuwa; Moran Choe; Ross Lake; Michael Kruhlak; Mayank Tandon; Zhenyu Cai; Swati Choksi; Zheng-Gang Liu
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

9.  TNF-α Triggers RIP1/FADD/Caspase-8-Mediated Apoptosis of Astrocytes and RIP3/MLKL-Mediated Necroptosis of Neurons Induced by Angiostrongylus cantonensis Infection.

Authors:  Hongli Zhou; Minyu Zhou; Yue Hu; Yanin Limpanon; Yubin Ma; Ping Huang; Paron Dekumyoy; Wanchai Maleewong; Zhiyue Lv
Journal:  Cell Mol Neurobiol       Date:  2021-03-08       Impact factor: 4.231

10.  Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis.

Authors:  Heather Koehler; Samantha Cotsmire; Ting Zhang; Siddharth Balachandran; Jason W Upton; Jeffery Langland; Daniel Kalman; Bertram L Jacobs; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2021-06-29       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.